Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 10Stomach Neoplasms 9Neoplasm Metastasis 8Breast Neoplasms 8Esophageal Neoplasms 7Colorectal Neoplasms 6Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5Leukemia, Myeloid, Acute 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4Nasopharyngeal Carcinoma 4Esophageal Squamous Cell Carcinoma 4Adenocarcinoma Of Esophagus 4Uterine Cervical Neoplasms 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Mouth Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Glioma 2Endometrial Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Ovarian Epithelial 2Anus Neoplasms 2Anatomic Stage II Breast Cancer AJCC v8 2

Interventions

pembrolizumab 28Cisplatin 19Carboplatin 14Radiotherapy 11Paclitaxel 10Cetuximab 10Surveys and Questionnaires 7Radiotherapy, Intensity-Modulated 5Docetaxel 5Surgical Procedures, Operative 4Fluorouracil 4Chemoradiotherapy 4dostarlimab 3Therapeutics 3Nivolumab 3Drug Therapy 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3toripalimab 2tislelizumab 2nimotuzumab 2cemiplimab 2abemaciclib 2X-Rays 2Taxes 2Standard of Care 2Radiosurgery 2Radiation 2Pemetrexed 2Methotrexate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Drug Therapy × 90 days × Clear all
NCT07209189 2026-04-23

(NeoScorch HN)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
75 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT06477692 2026-04-17

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

University of Texas Southwestern Medical Center

Phase 2 Recruiting
80 enrolled
Head & Neck

Head and Neck Neoplasms

NCT07447570 2026-03-03

Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
27 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡